Me kuke nufi, "HCV RNA gano"? Analysis na HCV RNA

Kamu da hepatitis C iya kowane. Mutane da yawa rayuwa da cutar na shekaru da kuma ba su ma san cewa sun kaddamar a wani inji cewa jima ko daga baya kai ga mummunan sakamako. Irin wadannan mutane rayayye harba wasu, da kuma kudi na abin da ya faru an ci gaba da karuwa. Don rage wadannan Figures, daya kamata su sa shi mai mulkin ya sha lokaci-lokaci analysis for hepatitis C, musamman idan ta ne a hadarin.

Brief bayanai game da cutar

Hepatitis C virus (HCV) RNA kwayoyin qunshi dauke da kwayoyin bayanai da kuma musamman sunadarai wanda hulɗa tare da jikin mutum. Jima'i, yafi ta hanyar jini da kuma. A wasu lokuta, zai yiwu a tsaye watsa (t. E. Daga uwa zuwa yaro).

Iya shiga a cikin jiki, shi settles a daban-daban da maikacin jini (neutrophils, monocytes, lymphocytes) da kuma hanta (hepatocytes).

Kaidinsu kamuwa da cuta shi ne babu bayyanar cututtuka na m lokaci. Yana nan da nan ya zama na kullum asymptomatic da kuma jinkirin bada ta hallakaswa sakamako.

effects

Daga farkon shigar azzakari cikin farji cikin jikin HCV RNA kafin na farko bayyanar cututtuka zai iya daukar shekaru masu yawa, wani lokacin ga 15-20 shekaru ko fiye. Ana zargin gunaguni hankula ga ci-gaba siffofin hepatitis C, a lokacin da hanta da aka riga muhimmanci shafa. Mafi yawan wadannan marasa lafiya bincikar lafiya wadannan hanta cututtuka:

• cirrhosis.
• necrosis.
• benign cysts.
• Oncology.

Kafin ci gaban da rikitarwa da haƙuri kiyaye kadan indisposition, wanda yawanci ba dora muhimmanci.

Don gudanar da wani bincike

Analysis na HCV RNA da aka nuna wa mutanen da suke da mafi yiwuwa ga kamuwa da cuta. A cikin irin wannan rukuni ne:

• addicts.
• mutane ne promiscuous.
• duk wanda ya gudanar da aiki unprotected jima'i ayyukan, musamman tare da wani sabon abokin;
• magoya tattoo, sokin, shagon na gyaran gashi (hairdressers).
• mutane da suke halartar m hanyoyin (ciki har da haihuwa, hakori cuta).
• Haife kafin shekarar 1990, da iyaye mata na yara (da cewa a lokacin da cutar ta ba tukuna aka gano, don haka da transfussion na wadannan mata da aka kamuwa kamuwa);
• Yara da uwayensu.
• 'yan uwa da kuma jima'i abokan na da kamuwa.
• Marasa lafiya da na kullum cutar hanta da ba a sani ba yanayi.

A jerin ne quite m, don haka 'yan wanda zai iya ce tare da amincewa da cewa hadarin kamuwa da cuta shi ne sifili.

home gwaji

Mutane da yawa son da za a gwada wa tabbatar da dalilin da HCV RNA, amma ba je likita domin kunya, rashin lokaci, qiyayyarsu da asibitoci da sauransu. N.

Zai taimaka wajen warware matsalar da sauki ganewar asali yin amfani da musamman m kima (Elisha). A wannan yanayin, wani ingantaccen Hanyar kayyade kawai gaskiyar gaban antibodies da cutar.

Yana aiki a kan manufa da gwajin for ciki, amma a matsayin gwajin kayan bukata jini:

1. Complete da roba tsiri (duba for kimantawa) ne na musamman Lancet, sokin yatsa a touch of a button.
2. Tare da wani ɓangare na pipette jini da aka sanya a cikin wani na musamman daki, kuma bayan 10-15 minti kimanta martani.
3. Sanduna biyu nuna sakamakon tabbatacce, daya - a kan korau. Kodadde bayyanar wani biyu tabo a cikin gwajin zone nuna gaban cuta, duk da haka, maida hankali antibodies a cikin jini ne ma low.

Idan da cutar da aka gano, shi wajibi ne don zuwa likita domin kara jarrabawa.

A ka'idodi na ganewa na HCV RNA

Tare da wadannan sakamakon shi wajibi ne don jũya zuwa ga cututtuka da kuma hepatology, wanda zai sanya wani ƙarin jarrabawa.

Babban abu a gudanar da wani karin bincike - don gane wa wanda genotype hada da gano hepatitis, da kuma sanin da adadin a cikin jini. Daga cikin bayanan samu zai dogara kan kara magani, tun lokacin duk iri bambanta da juna, kuma suna iya amsa daban zuwa kwayoyi. Bugu da kari, microorganisms ne iya basira masked.

-daban na gudanar da bincike

A ganewar asali HCV amfani da daya daga cikin wadannan hanyoyin:

1. PCR. A wannan yanayin da muke magana ne game da kayyade abu na pathogen.
2. Gwada yawa bincike na HCV RNA (r-DNK, TMA). Irin wannan bincike ne da za'ayi bayan tabbatarwa daga gaban pathogen a cikin jiki. Haka kuma an kira kwayar load. Yana ba ka damar gano yawan pathogenic wakilan a 1 ml na jini. Daga wadannan Manuniya shi ya dogara da duration na jiyya da kuma mataki na infectiousness na haƙuri. R-DNK aikin gwaji a cikin kewayon sama da 500 ME, da kuma TMA a 5-10 ni. Duka hanyoyin da ake dauke su sauki da kuma cheap.
3. Genotyping. Yana yi karshe da kuma damar zuwa saka wa wanda nau'in hada da gano cutar.

Evaluation na da sakamakon

Idan da bincike na HCV RNA ya m da PCR kuma Elisha, da ganewar asali aka tabbatar. Duk da haka, wani mummunan sakamakon ba ya bayar da tabbacin babu kamuwa da cuta. Abin baƙin ciki, shi ya faru sau da yawa saboda tsari za a iya amfani da reactants da daban-daban sensitivities.

Mutane da yawa mamaki da abin da ake nufi da, "HCV RNA gano". Wannan shaida iya gaske nuna babu cuta, ko ta low taro. Alal misali, PCR 200 ME / ML ba ƙarya sakamakon idan haƙuri yawan kwayar kofe dan kadan. Wannan zai iya faruwa a lokacin da wani 'yan kamuwa da cuta, ko a lokacin da magani.

Sau da yawa haƙuri ba ya bukatar ya mallaki irin wannan bayani, tun da wadannan maki ya kamata a dauka a cikin asusun da halartar likita.

Ganewa na HCV RNA a gwada yawa bincike a kan 400 000 ME kuma mafi ce da cutar ne ba kawai ba a cikin jini, amma kuma rayayye karbe, haka infecting sauransu. Idan index ne kusa da 800 000, shi ne da ke nuni da m lokaci da kuma aiki da hanta da cutar Kwayoyin.

Ko da yake akwai gwani ra'ayi diverge. Wasu daga cikin su bayar da hujjar cewa dangantaka tare da gudun ci gaban da cutar da kuma yawan kofe na cutar can.

Irin wannan marasa lafiya bukatar ya zama musamman hankali a sadarwa da waɗanda suke ƙauna.

ƙarin bincike

Bayan kayyade HCV RNA da sauran nazarin za a iya sanya wani haƙuri, hada da:

• ganewa na hepatitis B;
• janar bincike na jini da kuma fitsari.
• Biochemistry.
• Duban dan na ciki.
• MRI ko CT scans na hanta (nuna).

Bayan samun dukan zama dole bayani likita a hankali nazarin sakamakon, haƙuri da kiwon lafiya matsayi, sa'an nan kuma ance mutum magani makirci a gare shi.

Lokacin dace ganewa na hanta lalacewa, yawanci ba a nan.

Warkewa hanyoyin da lokaci

A tsawon lokaci da magani dogara a kan genotype. A yau mun san 11 jinsunan wanda 6 ne ya fi kowa. A Rasha, ya fi na kowa 1, 2 3rd irin.

A 'yan shekaru da suka wuce hepatitis C yana daga wani rukuni na m cututtuka. Far gudanar da yafi interferons, zai iya muhimmanci inganta da yanayin haƙuri, amma ba warkar da shi gaba daya.

Nasara a lura da cutar ya zama wani magani "sofosbuvir," abin da ya bayyana a Pharmacy karkashin wani daban-daban cinikayya sunan "Sovaldi". Don kwanan wata, akwai da dama tasiri wajen analogues:

• "Viropak".
• "Gratitsiano".
• "Geptsinat".
• "Gopetavir".

Sau da yawa, suna da kyau jure da marasa lafiya, amma a wasu lokuta ana lura:

• ciwon kai.
• tashin zuciya.
• rashin barci.
• ci hasara.
• convulsions.
• migraine.
• ciki;
• a ji na rashin ruwa a bakin.
• ciwon kirji.
• gashi hasara.

The kawai drawback na irin wannan magani - sayar da tsada (wani talakawan na 10 000-12000 p ta shirya.), Wanne, dangane da zabi medicament iya bambanta zuwa sama ko ƙasa.

reinvestigation

Bayan da magani, zaunanniya daga 12 zuwa 24 makonni, da mãsu haƙuri za a sanya maimaita analysis for gaban kwayar RNA a cikin jini.

A wannan yanayin, da hanyar da mafi ƙarancin dokin ƙwarai dole ne a yi amfani, tun bayan daukan hotuna zuwa HCV miyagun ƙwayoyi taro iya zama negligible. A wannan yanayin da magani dole ne a ci gaba.

A korau sakamakon shi ne rashin hepatitis C cutar RNA a lokacin da pathogen da aka gano. Irin wannan binciken zai bukatar mu ciyar da wasu karin lokaci (a short jinkiri), don tabbatar da cewa maganin da aka ci nasara.

rigakafin

Duk wanda ya kasance mai tsawo da kuma tsada jiyya ga hepatitis C, yana da daraja tuna cewa ta jikinsa ba ya nuna rigakafi, don haka reinfection mai yiwuwa ne.

A cuta ne sauki su hana fiye da zuwa magani. Cikakken kare kanka daga yiwu hadari ba ya aiki, amma domin sa'an nan ba dole tambaye abin da ake nufi, "HCV RNA gano", wadannan sauna ya kamata a lura:

• ba su yi amfani da wasu mutane ta sirri kiwon lafiya abubuwa (Rezoji, almakashi, hakori yarns).
• Guji unprotected jima'i.
• ziyarci likitan hakori, gyaran gashi (kyakkyawa, tattoo, da dai sauransu ...) kawai tare da suna mai kyau.
• rufe duk plaster ko bandeji fata lalacewa.
• kamar yadda ya zuwa yanzu kamar yadda zai yiwu a kauce wa lamba tare da mai cutar.

Outlook

A baya cutar da aka gano, da mafi tasiri da magani zai zama. Yawanci, a cikin rashi na ciki sashin jiki hepatitis C za a iya warke gaba daya, kuma ba tare da sakamakon.

Idan bar untreated hepatitis C, zai jima ko daga baya kai ga cirrhosis ko hanta ciwon daji. Wannan zai iya faruwa ko bayan 30-40 shekaru bãyan ƙulla da cutar.

Cirrhosis, abin da ya bayyana a ƙarƙashin rinjayar hepatitis C ne a kullum m cutar. A ta farkon matakai shi ne mai yiwuwa a rage gudu da kwarara a cikin hali na gudãna kawai iya ajiye mutum hanta dasawa.

Bayan koyo daga cikin sakamakon tabbatacce ga hepatitis C, ba nan da nan tsoro. Da farko, dole ne ka duba yanayin da hanta da kuma fara zuwa yãƙi cututtuka da kuma comorbidities. A lura shi ne tsawo da tsada, amma ya ba da haƙuri da damar a dogon da lafiya rai.